Aydin Huseynov

Stock Analyst at Ladenburg Thalmann

(0.71)
# 4,013
Out of 5,022 analysts
58
Total ratings
32%
Success rate
-25.47%
Average return

Stocks Rated by Aydin Huseynov

Ardelyx
Mar 7, 2025
Assumes: Buy
Price Target: $11
Current: $5.01
Upside: +119.56%
UroGen Pharma
Feb 19, 2025
Assumes: Buy
Price Target: $31
Current: $16.76
Upside: +84.96%
Marker Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $11$19
Current: $1.02
Upside: +1,762.75%
Corvus Pharmaceuticals
Sep 16, 2024
Maintains: Buy
Price Target: $12$21
Current: $7.11
Upside: +195.36%
Compass Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $5
Current: $4.29
Upside: +16.69%
Acrivon Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $16
Current: $1.77
Upside: +803.95%
Calidi Biotherapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $120
Current: $1.63
Upside: +7,261.96%
Capricor Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $24$25
Current: $6.72
Upside: +272.02%
Spruce Biosciences
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $159.01
Upside: -
Biodexa Pharmaceuticals
Feb 8, 2024
Initiates: Buy
Price Target: $2,000
Current: $7.83
Upside: +25,442.78%
Initiates: Buy
Price Target: $7
Current: $1.32
Upside: +430.30%
Initiates: Buy
Price Target: $10
Current: $3.86
Upside: +159.07%
Initiates: Buy
Price Target: $60
Current: $15.55
Upside: +285.85%
Maintains: Buy
Price Target: $10$6
Current: $1.80
Upside: +233.33%
Maintains: Buy
Price Target: $20$10
Current: $4.66
Upside: +114.59%
Maintains: Buy
Price Target: $375$240
Current: $1.85
Upside: +12,872.97%
Maintains: Buy
Price Target: $104$182
Current: $11.53
Upside: +1,478.49%
Maintains: Speculative Buy
Price Target: $180$80
Current: $0.44
Upside: +18,036.48%
Initiates: Buy
Price Target: $20
Current: $4.16
Upside: +380.77%
Downgrades: Neutral
Price Target: n/a
Current: $6.35
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.53
Upside: -
Initiates: Buy
Price Target: $6
Current: $2.32
Upside: +158.62%
Initiates: Buy
Price Target: $21
Current: $6.16
Upside: +240.91%
Initiates: Buy
Price Target: $10,500
Current: $14.86
Upside: +70,559.49%
Initiates: Buy
Price Target: $37
Current: $1.66
Upside: +2,128.92%
Upgrades: Buy
Price Target: $300
Current: $57.40
Upside: +422.65%
Downgrades: Hold
Price Target: n/a
Current: $557.73
Upside: -
Upgrades: Buy
Price Target: $89
Current: $84.73
Upside: +5.04%
Initiates: Hold
Price Target: n/a
Current: $137.35
Upside: -
Initiates: Speculative Buy
Price Target: $15,000
Current: $3.96
Upside: +378,687.88%
Initiates: Buy
Price Target: $336
Current: $2.47
Upside: +13,503.24%
Initiates: Buy
Price Target: $18
Current: $4.89
Upside: +268.10%